Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Pechala's Reports
$15.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Edwards Lifesciences Corp Reaffirms FY 2013 Guidance-Conference Call


Tuesday, 11 Jun 2013 03:50pm EDT 

Edwards Lifesciences Corp announced that it is still expecting 10% growth at the top line and 13% growth at the bottom line for fiscal 2013. The Company reported revenue of $1.90 billion and EPS of $2.69 in fiscal 2012. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $2.05 billion and EPS of $3.05 for fiscal 2013. 

Company Quote

116.85
11.66 +11.08%
24 Oct 2014